Intrinsic Value of S&P & Nasdaq Contact Us

Tyme Technologies, Inc. TYME NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
1/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Tyme Technologies, Inc. (TYME) reported total assets of $80.16M and total liabilities of $6.02M for quarter ending 2022-06-30, resulting in total equity of $0.00.

The company held $77.11M in cash and short-term investments. Total debt stood at $26.49K, with net debt of $-6.39M.

Current ratio is 14.06, indicating strong short-term liquidity. Interest coverage is -546x (weak).

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (28/100) — Total assets $80.16M and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
28/100
Proven by this page
GROWTH
65/100
→ Income
INCOME
N/A
No coverage
Tyme Technologies, Inc. Balance Sheet History
Metric Q1 FY2023 Q4 FY2022 Q3 FY2022 Q2 FY2022
Total Assets $80.16M$88.02M$93M$97.81M
Total Liabilities $6.02M$7.93M$6.31M$6.3M
Total Debt $26.49K$37.33K$47.88K$58.15K
Cash & Investments $77.11M$74.35M$75.06M$75.51M
Total Stockholders Equity $74.14M$80.08M$86.69M$91.51M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message